EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1

Rachel I Gafni iD, Iris R Hartley iD, Kelly L Roszko, Edward F Nemeth, Karen A Pozo, Ed Lombardi, Ananth V Sridhar, Mary S Roberts, Jonathan C Fox, Michael T Collins

New England Journal of Medicine · 28.09.2023 · 389 (13) · 1245-1247

DOI: 10.1056/nejmc2302708 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 28.09.2023. Verfasst von Rachel I Gafni und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes of Health, Bethesda, MD gafnir@nih.gov. Hauptthemen laut MEDLINE: Hypoparathyroidism, Calcium-Regulating Hormones and Agents, Hypocalcemia. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoparathyroidismCalcium-Regulating Hormones and AgentsHypocalcemiaMutationHypercalciuriaHumansCalciumGenes, DominantTreatment Outcome

Substanzen

CalciumCalcium-Regulating Hormones and Agents

Autor:innen und Institutionen

  • National Institutes of Health, Bethesda, MD gafnir@nih.gov.
  • MetisMedica, Toronto, ON, Canada.
  • National Institutes of Health, Bethesda, MD.
  • BridgeBio Pharma, San Francisco, CA.
  • National Institutes of Health, Bethesda, MD mcollins@dir.nidcr.nih.gov.

ORCID-Profile: Rachel I Gafni, Iris R Hartley

Förderung

  • Intramural NIH HHS
  • NIDCR NIH HHS
  • National Institute of Dental and Craniofacial Research
  • Calcilytix Therapeutics

Zitieren

APA

Gafni, R. I., Hartley, I. R., Roszko, K. L., Nemeth, E. F., Pozo, K. A., Lombardi, E., Sridhar, A. V., Roberts, M. S., Fox, J. C., & Collins, M. T. (2023). Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1. New England Journal of Medicine, 389(13), 1245-1247. https://doi.org/10.1056/nejmc2302708

Vancouver

Gafni RI, Hartley IR, Roszko KL, Nemeth EF, Pozo KA, Lombardi E, et al. Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1. New England Journal of Medicine. 2023;389(13):1245-1247. doi:10.1056/nejmc2302708

BibTeX
@article{Gafni2023,
  author = {Gafni, Rachel I and Hartley, Iris R and Roszko, Kelly L and Nemeth, Edward F and Pozo, Karen A and Lombardi, Ed and Sridhar, Ananth V and Roberts, Mary S and Fox, Jonathan C and Collins, Michael T},
  title = {Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {13},
  pages = {1245--1247},
  doi = {10.1056/nejmc2302708}
}
Kostenlos starten →